Skip to main content
. 2019 Dec 9;69(8):1460–1471. doi: 10.1136/gutjnl-2019-319313

Table 1.

Summary of ‘credible positive associations’ from meta-analyses and credibility assessment

Gene Variant Cases vs controls
(number of samples)
Allelic model Power Recessive model: var/var vs wt/wt and wt/var Dominant model: wt/var and var/var vs wt/wt Classification
N Effect size Heterogeneity N Effect size Heterogeneity Power N Effect size Heterogeneity Power
OR (95% CI) P value I2 (95% CI) P value OR (95% CI) P value I2 (95% CI) P value OR (95% CI) P value I2 (95% CI) P value
MUTYH rs36053993 28 302 vs 20 935 (19*) 19 1.42 (1.22 to 1.66) 4.89E-06 0 (0 to 33) 0.703 0.99 na na na na na na 19 1.31 (1.12 to 1.53) 0.001 0 (0 to 24) 0.837 0.88 Positive
MUTYH rs34612342 28 180 vs 20 923 (19*) 17 1.89 (1.47 to 2.42) 5.72E-07 0 (0 to 62) 0.828 1.00 7 3.40 (1.22 to 9.48) 0.019 0 (0 to 0) 0.998 1.00 17 1.80 (1.39 to 2.31) 6.42E-06 0 (0 to 52) 0.884 1.00 Positive
SMAD7 rs12953717 28 006 vs 26 539 (13*) 13 1.11 (1.07 to 1.16) 6.24E-07 49 (0 to 93) 0.024 1.00 13 1.17 (1.08 to 1.26) 8.34E-05 45 (0 to 94) 0.041 1.00 13 1.14 (1.07 to 1.21) 5.00E-05 54 (10 to 95) 0.020 1.00 Positive
SMAD7 rs4464148 17 772 vs 17 356 (9*) 9 1.12 (1.08 to 1.16) 2.66E-09 12 (0 to 92) 0.337 1.00 9 1.13 (1.00 to 1.28) 0.054 49 (0 to 98) 0.047 0.97 9 1.16 (1.11 to 1.21) 2.09E-10 2 (0 to 86) 0.416 1.00 Positive
8q24 rs10505477 18 562 vs 20 132 (14) 14 1.14 (1.10 to 1.19) 2.04E-11 44 (0 to 82) 0.040 1.00 14 1.16 (1.10 to 1.23) 4.06E-07 35 (0 to 74) 0.092 1.00 14 1.24 (1.17 to 1.32) 1.04E-11 36 (0 to 81) 0.084 1.00 Positive
20p12.3 rs961253 22 971 vs 25 270 (14*) 14 1.11 (1.06 to 1.16) 1.58E-05 60 (28 to 91) 0.002 1.00 13 1.14 (1.06 to 1.22) 7.10E-04 36 (0 to 96) 0.098 1.00 14 1.14 (1.07 to 1.21) 4.75E-05 57 (21 to 88) 0.004 1.00 Positive
8q23.3 rs16892766 8351 vs 8878 (6*) 6 1.24 (1.15 to 1.34) 1.67E-08 4 (0 to 92) 0.393 0.99 6 1.21 (0.88 to 1.67) 0.240 0 (0 to 85) 0.747 0.22 6 1.27 (1.17 to 1.38) 4.00E-09 3 (0 to 90) 0.400 1.00 Positive
10p14 rs10795668 16 763 vs 18 302 (16*) 16 0.88 (0.83 to 0.94) 4.35E-05 67 (34 to 89) 6.94E-05 1.00 16 0.83 (0.77 to 0.89) 4.77E-07 11 (0 to 70) 0.332 1.00 16 0.85 (0.79 to 0.93) 2.27E-04 68 (34 to 87) 3.06E-05 1.00 Positive
11q23.1 rs3802842 22 320 vs 22 965 (20*) 20 1.15 (1.11 to 1.20) 5.21E-12 43 (0 to 78) 0.024 1.00 20 1.24 (1.13 to 1.35) 3.62E-06 45 (5 to 86) 0.017 1.00 20 1.19 (1.13 to 1.25) 7.22E-12 33 (0 to 70) 0.075 1.00 Positive
BMP2 rs355527 13 539 vs 14 375 (9) 9 1.12 (1.08 to 1.17) 1.65E-10 0 (0 to 0) 0.977 0.99 9 1.18 (1.09 to 1.27) 3.54E-05 0 (0 to 94) 0.458 0.99 9 1.16 (1.10 to 1.21) 2.43E-09 0 (0 to 9) 0.966 1.00 Positive
CDH1 rs1862748 17 436 vs 18 418 (11) 11 0.91 (0.88 to 0.94) 1.98E-08 0 (0 to 63) 0.703 0.98 11 0.83 (0.77 to 0.90) 1.59E-06 2 (0 to 68) 0.427 1.00 11 0.91 (0.87 to 0.95) 6.31E-06 0 (0 to 70) 0.511 0.99 Positive
RHPN2 rs7259371 15 762 vs 16 700 (9*) 9 0.87 (0.82 to 0.93) 1.65E-05 52 (0 to 90) 0.034 1.00 9 0.85 (0.73 to 0.98) 0.027 17 (0 to 86) 0.295 0.71 9 0.86 (0.80 to 0.92) 3.81E-06 42 (0 to 87) 0.084 1.00 Positive
TERT rs2736100 16 176 vs 18 135 (8) 8 1.07 (1.04 to 1.10) 2.95E-05 0 (0 to 82) 0.526 0.88 8 1.06 (1.00 to 1.13) 0.069 15 (0 to 86) 0.316 0.64 8 1.13 (1.08 to 1.20) 2.03E-06 0 (0 to 64) 0.788 1.00 Positive
TGFB1 rs1800469 4021 vs 6024 (10) 10 0.89 (0.80 to 0.99) 0.036 53(2t o 92) 0.023 1.00 10 0.84 (0.74 to 0.94) 0.003 0 (0 to 75) 0.527 1.00 10 0.84 (0.71 to 1.00) 0.051 58 (15 to 92) 0.011 1.00 Positive

*Includes GWAS data from SOCCS.

GWASs, genome-wide association studies; SOCCS, Study of CRC in Scotland.